메지온
59,800KRWMarket close of 10/21 (Wed)
Up +1.87%+1,100KRWMarket close of 10/21 (Wed)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)57,500KRWDown -3.85%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 58,800
- High
- 60,600
- Low
- 58,800
- Day range
- Day range low 58,800 high 60,600, open 58,800, close 59,800, previous close 58,700
- Volume
- 5×10K shares
- 3.1B KRW 0.41× the 20-session average
Market close of 10/21 (Wed)
Where it sits in the 1-year range
7%1-year close range 51,000 to 172,700 won, 7% up from the low
7% of the way up from the lowest close in 1 year (252 sessions) · -65.4% from the high
Something to check
1 to check: operating loss
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsto check-18.8B KRWOperating income over the last four quarters -18.8B KRW (loss)
- Daily moveusual range+1.87%+1.87%, 0.5× the usual (20-session average ±3.49%)That day +1.87% · usual ±3.49% · large-move threshold ±7.0%
- Trading valueusual range0.4×3.1B KRW, 0.4× the 20-session average0.41× the 20-session average · check threshold 3×
The other 3 are within the usual range
- Recent filings0Last 14 days
- Foreign & institutional+200.00 million KRWusual range
- Data date10/21 (Wed)Market close
See the full check report
Same sector · 바이오 R&D
Up +3.03%· 33 of 64 stocks up, preferred shares excluded · trading value 215.2B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 알테오젠 | Close over the last 20 sessions -5.5% | Up +3.90% | 60.7B KRW |
| 올릭스 | Close over the last 20 sessions -6.4% | Up +9.53% | 26.1B KRW |
| 디앤디파마텍 | Close over the last 20 sessions -6.0% | Up +6.65% | 22.0B KRW |
| 리가켐바이오 | Close over the last 20 sessions -14.3% | Up +2.00% | 12.9B KRW |
| 프로티나 | Close over the last 20 sessions +35.7% | Up +7.23% | 11.0B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 24 days
- Next data 10/23 (Fri) after 08:50
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.